ProCE Banner Activity

Anticoagulant Reversal Strategies: Considerations for Health System Pharmacists

Clinical Thought

Here’s my take on key considerations when designing an inpatient anticoagulation reversal protocol, when selecting a reversal or replacement agent for a specific patient, and why I think the clinical trial data and not the cost of therapy should be an important factor in your clinical decision.

Released: January 09, 2024

Share

Faculty

Toby Trujillo

Toby Trujillo, PharmD, FCCP, FAHA, BCPS

Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Clinical Specialist, Cardiology/Anticoagulation
Co-director Anticoagulation Stewardship Program
University of Colorado Hospital/UC Health
Aurora, Colorado

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from CSL Behring LLC

CSL Behring LLC

Disclosure

Primary Author

Toby Trujillo, PharmD, FCCP, FAHA, BCPS

Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Clinical Specialist, Cardiology/Anticoagulation
Co-director Anticoagulation Stewardship Program
University of Colorado Hospital/UC Health
Aurora, Colorado

Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS, has no relevant financial relationships to disclose.